Summary of Purpose
This study evaluates safety and efficacy of analgesia-first minimal sedation as an early antihypertensive treatment for spontaneous intracerebral hemorrhage. The analgesia-first minimal sedation strategy relies on the remifentanil-mediated alleviation of pain-induced stress response and the antisympathetic activity of dexmedetomidine to restore the elevated blood pressure to normal level in patients with...Read More →
The following dates are available for this trial. Trial information last updated on 26 February 2018.
|1 Mar 2018||26 Jun 2017||1 Feb 2019||1 Aug 2019||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Interventions See All
Conditions See All
Sponsors See All